Devon Graham, PhD - Publications

Affiliations: 
Pharmacology Vanderbilt University School of Medicine, Nashville, TN, United States 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Goldfarb SS, Stanwood GD, Flynn HA, Graham DL. Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications. Experimental Biology and Medicine (Maywood, N.J.). 1535370219883601. PMID 31630569 DOI: 10.1177/1535370219883601  0.6
2016 Martin MM, Graham DL, McCarthy DM, Bhide PG, Stanwood GD. Cocaine-induced neurodevelopmental deficits and underlying mechanisms. Birth Defects Research. Part C, Embryo Today : Reviews. 108: 147-73. PMID 27345015 DOI: 10.1002/bdrc.21132  0.6
2016 Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, et al. Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Translational Psychiatry. 6: e809. PMID 27187231 DOI: 10.1038/tp.2016.86  0.6
2015 Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiology & Behavior. 149: 262-8. PMID 26072178 DOI: 10.1016/j.physbeh.2015.06.013  0.6
2015 Graham DL, Buendia MA, Chapman MA, Durai HH, Stanwood GD. Deletion of Gαq in the telencephalon alters specific neurobehavioral outcomes. Synapse (New York, N.Y.). PMID 25963901 DOI: 10.1002/syn.21830  0.6
2015 Frederick AL, Yano H, Trifilieff P, Vishwasrao HD, Biezonski D, Mészáros J, Urizar E, Sibley DR, Kellendonk C, Sonntag KC, Graham DL, Colbran RJ, Stanwood GD, Javitch JA. Evidence against dopamine D1/D2 receptor heteromers. Molecular Psychiatry. PMID 25560761 DOI: 10.1038/mp.2014.166  0.6
2015 Vorhees CV, Graham DL, Braun AA, Schaefer TL, Skelton MR, Richtand NM, Williams MT. Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine. Neurotoxicology and Teratology. 47: 54-65. PMID 25450663 DOI: 10.1016/j.ntt.2014.10.007  0.6
2015 Graham DL, Durai HH, Garden JD, Cohen EL, Echevarria FD, Stanwood GD. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex. Acs Chemical Neuroscience. 6: 297-305. PMID 25393953 DOI: 10.1021/cn500235m  0.6
2015 Ross EJ, Graham DL, Money KM, Stanwood GD. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 61-87. PMID 24938210 DOI: 10.1038/npp.2014.147  0.6
2015 Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice Physiology and Behavior. 149: 262-268. DOI: 10.1016/j.physbeh.2015.06.013  0.6
2013 Graham DL, Erreger K, Galli A, Stanwood GD. GLP-1 analog attenuates cocaine reward. Molecular Psychiatry. 18: 961-2. PMID 23089631 DOI: 10.1038/mp.2012.141  0.6
Show low-probability matches.